These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. A discordance in rosiglitazone mediated insulin sensitization and skeletal muscle mitochondrial content/activity in Type 2 diabetes mellitus. Pagel-Langenickel I; Schwartz DR; Arena RA; Minerbi DC; Johnson DT; Waclawiw MA; Cannon RO; Balaban RS; Tripodi DJ; Sack MN Am J Physiol Heart Circ Physiol; 2007 Nov; 293(5):H2659-66. PubMed ID: 17890427 [TBL] [Abstract][Full Text] [Related]
27. Skeletal muscle mitochondria in insulin resistance: differences in intermyofibrillar versus subsarcolemmal subpopulations and relationship to metabolic flexibility. Chomentowski P; Coen PM; Radiková Z; Goodpaster BH; Toledo FG J Clin Endocrinol Metab; 2011 Feb; 96(2):494-503. PubMed ID: 21106709 [TBL] [Abstract][Full Text] [Related]
28. Nine days of intensive exercise training improves mitochondrial function but not insulin action in adult offspring of mothers with type 2 diabetes. Irving BA; Short KR; Nair KS; Stump CS J Clin Endocrinol Metab; 2011 Jul; 96(7):E1137-41. PubMed ID: 21508128 [TBL] [Abstract][Full Text] [Related]
29. Insulin regulation of mitochondrial proteins and oxidative phosphorylation in human muscle. Boirie Y Trends Endocrinol Metab; 2003 Nov; 14(9):393-4. PubMed ID: 14580754 [TBL] [Abstract][Full Text] [Related]
30. Pioglitazone-induced improvements in insulin sensitivity occur without concomitant changes in muscle mitochondrial function. Bajpeyi S; Pasarica M; Conley KE; Newcomer BR; Jubrias SA; Gamboa C; Murray K; Sereda O; Sparks LM; Smith SR Metabolism; 2017 Apr; 69():24-32. PubMed ID: 28285649 [TBL] [Abstract][Full Text] [Related]
31. Features of hepatic and skeletal muscle insulin resistance unique to type 1 diabetes. Bergman BC; Howard D; Schauer IE; Maahs DM; Snell-Bergeon JK; Eckel RH; Perreault L; Rewers M J Clin Endocrinol Metab; 2012 May; 97(5):1663-72. PubMed ID: 22362823 [TBL] [Abstract][Full Text] [Related]
32. Improved skeletal muscle oxidative enzyme activity and restoration of PGC-1 alpha and PPAR beta/delta gene expression upon rosiglitazone treatment in obese patients with type 2 diabetes mellitus. Mensink M; Hesselink MK; Russell AP; Schaart G; Sels JP; Schrauwen P Int J Obes (Lond); 2007 Aug; 31(8):1302-10. PubMed ID: 17310221 [TBL] [Abstract][Full Text] [Related]
33. Early or advanced stage type 2 diabetes is not accompanied by in vivo skeletal muscle mitochondrial dysfunction. De Feyter HM; van den Broek NM; Praet SF; Nicolay K; van Loon LJ; Prompers JJ Eur J Endocrinol; 2008 May; 158(5):643-53. PubMed ID: 18426822 [TBL] [Abstract][Full Text] [Related]
34. Markers of mitochondrial biogenesis and metabolism are lower in overweight and obese insulin-resistant subjects. Heilbronn LK; Gan SK; Turner N; Campbell LV; Chisholm DJ J Clin Endocrinol Metab; 2007 Apr; 92(4):1467-73. PubMed ID: 17244782 [TBL] [Abstract][Full Text] [Related]
35. Value of dynamic ³¹P magnetic resonance spectroscopy technique in in vivo assessment of the skeletal muscle mitochondrial function in type 2 diabetes. Wu FY; Tu HJ; Qin B; Chen T; Xu HF; Qi J; Wang DH Chin Med J (Engl); 2012 Jan; 125(2):281-6. PubMed ID: 22340560 [TBL] [Abstract][Full Text] [Related]